My main point is that only a few hundred patients will be on drug in the first year long enough to determine adverse or ineffective results. 600 patients will start after June and therefore not assessed for discontinuation until end of year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.